Business Context and Reporting Period
This Form 8-K was filed by Flotek Industries, Inc. on March 8, 2022. The report details corporate governance actions taken by the Board of Directors and the Compensation Committee regarding executive appointments, compensation adjustments, and equity awards.
Key Financial Metrics
The filing does not provide financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive personnel and compensation matters.
Material Changes
- Executive Appointment: Ryan Ezell was appointed as Chief Operating Officer, effective March 8, 2022.
- Base Salary Adjustments: Executive base salaries were reviewed and adjusted effective March 8, 2022, based on peer comparisons and expected revenue impacts from transactions with ProFrac Holdings, LLC and ProFrac Services, LLC.
- John W. Gibson, Jr. (Chairman, CEO & President): $600,000
- Ryan Ezell (COO): Increased from $350,000 to $425,000
- Michael Borton (CFO): $360,000
- James Silas (SVP, Research & Innovation): $325,000
- Nicholas J. Bigney (SVP, General Counsel): $325,000
- Short-Term Incentives: The Compensation Committee determined that criteria for 2021 short-term incentive bonuses were not met; no bonuses will be awarded.
- Retention Equity Awards: Restricted common stock was granted to three executives:
- Dr. Ezell: $150,000 value
- Dr. Silas: $100,000 value
- Mr. Bigney: $100,000 value
Guidance, Outlook, and Risks
The filing references previously announced transactions with ProFrac Holdings, LLC and ProFrac Services, LLC as a factor in the salary review, noting an expected revenue impact. No specific financial guidance, forward-looking projections, or new risk factors were disclosed in this report.
Investor Verification Checklist
- Verify the terms of the previously announced transactions with ProFrac Holdings, LLC and ProFrac Services, LLC (filed Feb 4, 2022, and Feb 17, 2022) to understand the revenue impact cited for salary adjustments.
- Review the specific vesting schedules and performance conditions attached to the retention equity awards granted on March 8, 2022.
- Confirm the details of Dr. Ezell's employment agreement filed on January 6, 2021, as referenced in the text.
- Monitor future filings for the actual financial impact of the ProFrac transactions on the company's revenue and margins.